Holen Sie sich die Stockscreener-App
0.3124
8.14%
-0.0277
Handel nachbörslich:
.32
0.0076
+2.43%
Schlusskurs vom Vortag:
$0.3401
Offen:
$0.34
24-Stunden-Volumen:
788.02K
Relative Volume:
0.44
Marktkapitalisierung:
$21.12M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-18.65M
KGV:
-0.7116
EPS:
-0.439
Netto-Cashflow:
$-16.66M
1W Leistung:
-28.18%
1M Leistung:
+24.46%
6M Leistung:
-42.45%
1J Leistung:
-69.07%
1-Tages-Spanne:
$0.305
$0.3891
1-Wochen-Bereich:
$0.305
$0.457
52-Wochen-Spanne:
$0.2201
$1.53
Fibrobiologics Inc Stock (FBLG) Company Profile
Firmenname
Fibrobiologics Inc
Sektor
Branche
Telefon
281-671-5150
Adresse
455 E. MEDICAL CENTER BLVD, HOUSTON
Compare FBLG vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FBLG
Fibrobiologics Inc
|
0.3124 | 22.99M | 0 | -18.65M | -16.66M | -0.439 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.34 | 121.46B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.77 | 78.93B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
700.45 | 43.87B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.41 | 42.07B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.05 | 31.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Fibrobiologics Inc Stock (FBLG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-12 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-10-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-09-24 | Eingeleitet | Maxim Group | Buy |
Fibrobiologics Inc Aktie (FBLG) Neueste Nachrichten
FibroBiologics (NASDAQ: FBLG) adds 2025 governance, pay and ownership details - Stock Titan
FibroBiologics: CYWC628 Drives Buy Rating on Strong Preclinical Wound and Burn Data in Large Underserved Markets - TipRanks
D. Boral Capital Reiterates 'Buy' Rating for FibroBiologics - National Today
FibroBiologics Announces Advances in Burn Treatment Using Proprietary Fibroblast Spheroid Technology - Bitget
Experimental cell-based treatment aims to speed healing for severe burns - Stock Titan
Gainers Report: Is FibroBiologics Inc benefiting from interest rate changesQuarterly Portfolio Summary & Safe Capital Growth Trade Ideas - baoquankhu1.vn
FibroBiologics Updates CFO Compensation to Support Leadership - TipRanks
FibroBiologics sets new annual salary for CFO Jason D. Davis - Investing.com
FibroBiologics sets new annual salary for CFO Jason D. Davis By Investing.com - Investing.com Canada
FibroBiologics Completes Site Onboarding for Phase 1/2 Clinical Trial for CYWC628 for the Treatment of Refractory Diabetic Foot Ulcers - Sahm
FibroBiologics completes site onboarding for diabetic ulcer trial By Investing.com - Investing.com Canada
Top Executive Makes Bold Move Into FibroBiologics Stock - TipRanks
FibroBiologics completes site onboarding for diabetic ulcer trial - Investing.com
FibroBiologics (FBLG) CSO Khoja buys $11k in stock - Investing.com
FibroBiologics (FBLG) CSO Khoja buys $11k in stock By Investing.com - Investing.com Canada
FibroBiologics Completes Site Onboarding for Phase 1/2 - GlobeNewswire
CEO Doubles Down on FibroBiologics With Bold Insider Stock Purchase - TipRanks
FibroBiologics CFO Buys 70,000 Shares - National Today
CFO’s Bold Insider Buy Sparks Fresh Buzz Around FibroBiologics Stock - TipRanks
Davis Jason, FibroBiologics CFO, buys $28973 in FBLG stock By Investing.com - Investing.com Australia
Cell Therapies Moving From Lab to Factory Floor, and the Stocks Behind Them - Benzinga
Davis Jason, FibroBiologics CFO, buys $28973 in FBLG stock - Investing.com
FibroBiologics (FBLG) CFO purchases 70,000 shares in open-market trade - Stock Titan
FibroBiologics receives patent for osteoporosis cell therapy By Investing.com - Investing.com Canada
Insider Makes Bold New Bet on FibroBiologics Stock - TipRanks
FBLG Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
FibroBiologics Jumps 22% On New Osteoporosis Patent, Stock Up - Nasdaq
Garcia Ruben A, FibroBiologics general counsel, buys $13k in FBLG - Investing.com Australia
FibroBiologics receives patent for osteoporosis cell therapy - Investing.com
FibroBiologics, Inc. announces issuance of U.S. patent covering fibroblast cell therapy for the treatment of osteoporosis - marketscreener.com
Fibrobiologics, Inc. Announces Issuance Of U.S. Patent Covering Fibroblast Cell Therapy For The Treatment Of Osteoporosis - TradingView
FibroBiologics, Inc. Announces Issuance of U.S. Patent - GlobeNewswire
FibroBiologics, Inc. Announces Issuance of U.S. Patent Covering Fibroblast Cell Therapy for the Treatment of Osteoporosis - Bitget
FBLG: Ready to Transition to Clinical-Stage Company - Smartkarma
FibroBiologics to Present at the BIO Investment & Growth Summit - Bitget
H.C. Wainwright cuts FibroBiologics stock price target to $4 By Investing.com - Investing.com Canada
H.C. Wainwright cuts FibroBiologics stock price target to $4 - Investing.com Nigeria
FibroBiologics Reports Full Year 2025 Financial Results and Provides Corporate Update - Bitget
FibroBiologics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
FibroBiologics (FBLG) expands fibroblast-based cell therapy pipeline - Stock Titan
FibroBiologics gets Nasdaq extension to meet listing rules - Investing.com Australia
Finanzdaten der Fibrobiologics Inc-Aktie (FBLG)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):